“The fertility test market projected to grow at a CAGR of 7.2% during the forecast period.”
The global fertility test market is projected to reach USD 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%. Growth in the fertility test market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing. However, the unproven accuracy of urine-based ovulation monitors in PCOS/PCOD patients, and lesser precision of ovulation predictor kits to confirm ovulation are the major factors restricting market growth.
“The female fertility segment is expected to grow at the highest rate during the forecast period.”
On the basis of application, the global fertility test market has been segmented into female fertility testing and male fertility testing. The female fertility testing segment is expected to grow at the higher rate during the forecast period. Factors such as decreasing female fertility rates, availability of a wide range of fertility testing options, and high cost of IVF procedures are driving the high growth of this market segment.
“The home care settings segment accounted for the largest share of fertility test market”
On the basis of end user, the fertility test market is segmented into two major segments, namely, home care settings and hospitals, fertility clinics, and others. The home care settings segment is expected to account for the largest share of the market in 2018. This is mainly attributed to factors such as decline of fertility rates in women and men, increasing need for continuous monitoring of health conditions, and growing preference for home and remote monitoring.
“The APAC market is expected to grow at the highest CAGR during the forecast period”
Geographically, the fertility test market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The APAC market is expected to register the highest growth rate during the forecast period. The fast growth of this segment is mainly due to the growing number of women suffering from lifestyle disorders, increasing healthcare expenditure in these regions, rising funding/investments for the development of fertility and ovulation monitors. Moreover, as markets in developed countries are increasingly becoming saturated, manufacturers and suppliers of fertility test products are shifting their focus towards the Asian market, thereby driving the growth of this market during the forecast period.
Breakdown of supply-side primary interviews:
• By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation - C-level – 26%, Director level – 30%, Others – 44%
• By Region - North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%
The major players in the market included are SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), Prestige Brands Holdings (US), among others.
This report studies the fertility test market based on product, mode of purchase, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Reasons to Buy the Report:
This report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the fertility test market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.